CDC Will Test Travelers From Rwanda for Ebola-Like Marburg Virus
By Robin Foster HealthDay Reporter
TUESDAY, Oct. 8, 2024 -- As health officials work furiously to stem the spread of Marburg virus in Rwanda, U.S. health officials announced Monday that all passengers flying from that country to the United States will soon be screened for the often deadly disease.
"Starting the week of October 14, CDC [U.S. Centers for Disease Control and Prevention] will begin public health entry screening of travelers entering the United States who have been in Rwanda in the past 21 days," the U.S. Department of Health and Human Services said in a statement. "This screening aims to reduce the risk of importation of Marburg cases into the United States and the spread within U.S. communities."
As of Monday, 56 cases of Marburg had been confirmed in Rwanda, with 36 people in isolation and treatment, and 12 deaths, according to that country's Ministry of Health. No cases of Marburg virus have been reported in the United States at this point.
Travelers coming from Rwanda will be routed to one of three airports: Chicago O’Hare, JFK in New York and Washington Dulles in Virginia, the CDC said in a statement Monday, NBC News reported.
According to the statement, passengers landing at one of those airports will need to meet with CDC staffers for temperature checks and assessments of any other symptoms, such as sore throat, vomiting or rashes that often appear on the torso.
People infected by the virus can start showing symptoms two to 21 days after their exposure, according to the CDC.
Marburg is a virus that causes hemorrhagic fevers and internal bleeding, much like Ebola. Like Ebola, it spreads through contact with bodily fluids, including blood and semen. There is no treatment or vaccine. The death rate can be as high as 88%, according to the World Health Organization.
While the risk to the American public remains low, the CDC first began alerting U.S. doctors about Marburg last year.
In addition to the airport screening measures, the CDC issued a level 3 travel health notice on Monday, warning people against unnecessary travel to Rwanda.
The advisory suggested that anyone who must travel to the outbreak area watch for symptoms for 21 days.
“If you develop fever, chills, headache, muscle aches, rash, chest pain, sore throat, nausea, vomiting, diarrhea, or unexplained bleeding or bruising,” the advisory said, “isolate immediately and seek medical care.”
Sources
- U.S. Department of Health and Human Services, news release, Oct. 7, 2024
- U.S. Centers for Disease Control and Prevention, travel alert, Oct. 7, 2024
- NBC News
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Florida House Cat's Latest Conquest Yields New Virus Discovery
THURSDAY, July 17, 2025 — Florida virologist John Lednicky couldn’t have a more devoted research partner than his sleek black house cat Pepper. Pepper, an avid hunter...
CDC Says COVID-19 Cases Rising in 25 States
MONDAY, July 14, 2025 — COVID-19 cases are on the rise again across the United States, with the biggest increases in parts of the South, Southeast and West Coast. The U.S...
'Harmless' Virus Might Trigger Parkinson's Disease, Researchers Say
WEDNESDAY, July 9, 2025 — A common virus once thought harmless to humans might be linked to Parkinson’s disease, a new study says. The germ, Human Pegivirus (HPgV)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.